arrow
M

Martina Sanlorenzo

csic - centro nacional de biotecnologia (cnb)
H指数:27
被引数:2,465

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells

全身性IFN-I与局部TLR7/8激动剂联合应用,通过树突状细胞中c-Jun依赖性的IL-12表达促进远端肿瘤抑制。

2025-01-231
OA
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
2024-02-222
OAAI
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+Chemoresistant Lung Cancer Cells
2022-09-277
OAAI
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sezary Syndrome
2021-03-0132
OAAI
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (vol 28, pg 2517, 2017)
2019-03-0117
OAAI
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody
2018-07-1534
OAAI
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
2017-10-0194
OAAI
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
2017-04-3035
OAAI